This author has yet to write their bio.Meanwhile lets just say that we are proud Administrator contributed a whooping 1938 entries.
The deal will allow both companies to offer cohesive end-to-end commercial solutions to the life sciences industry. The partnership includes Havas Health & You taking a minority investment in Trinity.
The agency is kicking off 2023 with the promotion of George Abdy, Jr. to associate creative director of art.
Global healthcare communications company SCIRIS is delighted to announce the appointment of Isaac Batley as new CEO.
Chris Ozanian will be responsible for expanding on JUICE’S ongoing digital success with clients who are craving omnichannel leadership and a customer-focused approach to digital marketing.
Klick Group announced today that longtime McKinsey & Company executive Brian C. Fox has joined as President to help lead the company’s growth as the premier provider of end-to-end commercialization services for life sciences companies. Fox brings deep expertise in market strategy, product launches, sales force effectiveness, medical affairs, market access, clinical development, and corporate affairs.
Collazo will develop, maintain, and advance relationships between the agency and clients and lead cross-functional teams at Peregrine Market Access to develop and deliver market access and commercialization initiatives.
We know that a lack of diversity in healthcare settings can lead to harmful disparities in health outcomes, but a lack of diversity in messaging can also make people less likely to seek care in the first place. While social media influencers are working to change narratives and correct harmful assumptions around race, gender, and sex in the medical field, every sector of healthcare can work to understand the importance of diversity, conquer biases and stigma, and improve representation.
For a decade, RPV has specialized in connecting clients with patients and family caregivers for a variety of research studies.
2023 marks the 40th anniversary of the Orphan Drug Act (ODA) and kicks off a year of renewed hope and promise for developing rare disease medicines.
The healthcare marketing and analytics leader expands their Measurement Suite to include unprecedented audience and campaign insights.